REQUEST A DEMO
Total
USD $0.00
Search more companies

Savi Pharmaceutical Joint Stock Company (Vietnam)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Miscellaneous Food Manufacturing | Toilet Preparation Manufacturing | Warehousing and Storage
Full name: Savi Pharmaceutical Joint Stock Company Profile Updated: February 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

The subject operates in 3 major areas, including manufacturing drugs & similar to drug products; medicine storage & distribution and R&D – training (see detail in commentary below). It has existed in the pharmaceutical industry for 19 years. So, it has owned 230 licensed pharmaceutical products and successfully researched 12 treatment drug groups. It has implemented drug production and supply co-operation with 32 leading drug distribution enterprises in Vietnam.In addition, it has remained long relationship with a customer – GSK group since 2009 when it officially became a strategic partner of GSK group and received the entire system of GSK's global quality policy and quality management guidelines. Moreover, it has signed drugs supply contracts with 1,600 hospitals, medical centers, clinics and more than 10,000 pharmacies – pharmacy chains. Nonetheless, we do not collect official documents (customer list, contracts with GSK group, etc.) to ensure whether or not information is correct.

Headquarters
Lot Z01-02-03A, Industrial Park in Tan Thuan Export Processing Zone, Tan Thuan Dong Ward
Ho Chi Minh municipality; South Eastern Vietnam; Postal Code: 70000-74000

Contact Details: Purchase the Savi Pharmaceutical Joint Stock Company report to view the information.

Website: http://www.savipharm.vn

Basic Information
Total Employees:
Purchase the Savi Pharmaceutical Joint Stock Company report to view the information.
Outstanding Shares:
Purchase the Savi Pharmaceutical Joint Stock Company report to view the information.
Registered Capital:
Purchase the Savi Pharmaceutical Joint Stock Company report to view the information.
Incorporation Date:
August 03, 2005
Key Executives
Purchase this report to view the information.
General Director
Company Performance
Financial values in the chart are available after Savi Pharmaceutical Joint Stock Company report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
-1.64%
Total operating revenue
-1.64%
Operating profit (EBIT)
-12.02%
Net Profit (Loss) for the Period
-15.8%
Total assets
-1.5%
Total equity
9.81%
Operating Profit Margin (ROS)
-2.85%
Net Profit Margin
-3.43%
Return on Equity (ROE)
-6.18%
Debt to Equity Ratio
-12.39%
Quick Ratio
0.46%
Cash Ratio
0.24%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?